Skip to main content
Clinical Trials/ACTRN12618001273279
ACTRN12618001273279
Completed
未知

Risk-guided strategy for reducing readmission for Acute Decompensated Heart Failure

Baker Institute for Heart and Diabetes0 sites122 target enrollmentJuly 27, 2018

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Baker Institute for Heart and Diabetes
Enrollment
122
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 27, 2018
End Date
April 30, 2022
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Baker Institute for Heart and Diabetes

Eligibility Criteria

Inclusion Criteria

  • 1\. 18 years of age or older
  • 2\. Emergency Department admission with a primary diagnosis of Acute Decompensated Heart Failure confirmed by the treating physicians, in accordance with the HF guidelines.

Exclusion Criteria

  • 1\. Unable to provide written informed consent to participate in this study
  • 2\. Patients that need palliative care. Discussion with the physician and assessment of palliative care needs.
  • 3\. Participating in another clinical research trial where randomisation to study arms would be unacceptable
  • 4\. Patients who live in an aged care facility (eg. Nursing Home)
  • 5\. Moderate to severe primary mitral or aortic valve disease
  • 6\. Concomitant unstable angina, acute myocardial infarction
  • 7\. Cardiac device malfunction
  • 8\. Endocarditis
  • 9\. Patients with Left Ventricular Assistant Device (LVAD)
  • 10\. Patients with asymptomatic Left Ventricular (LV) dysfunction

Outcomes

Primary Outcomes

Not specified

Similar Trials